Bone health in cancer: ESMO Clinical Practice Guidelines | Annals of Oncology | 2020 | 82 |
EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort: Under the Auspices of the EAU-ESMO Guidelines Committees | European Urology | 2020 | 60 |
Optimizing the Quality of Colorectal Cancer Screening Worldwide | Gastroenterology | 2020 | 48 |
Long-Term Colorectal Cancer Incidence and Mortality After a Single Negative Screening Colonoscopy | Annals of Internal Medicine | 2020 | 28 |
Osimertinib in T790M-positive and -negative patients with EGFR-mutated advanced non-small cell lung cancer (the TREM-study) | Lung Cancer | 2020 | 21 |
Liver transplantation for unresectable colorectal liver metastases in patients and donors with extended criteria (SECA-II arm D study) | BJS Open | 2020 | 20 |
Preparation of the alpha-emitting prostate-specific membrane antigen targeted radioligand [ Pb]Pb-NG001 for prostate cancer | Journal of Labelled Compounds and Radiopharmaceuticals | 2020 | 18 |
Continuing increased risk of second cancer in long-term testicular cancer survivors after treatment in the cisplatin era | International Journal of Cancer | 2020 | 18 |
European Society of Gynaecological Oncology quality indicators for surgical treatment of cervical cancer | International Journal of Gynecological Cancer | 2020 | 16 |
The sacral chordoma margin | European Journal of Surgical Oncology | 2020 | 16 |
BRAF mutational status as a prognostic marker for survival in malignant melanoma: a systematic review and meta-analysis | Acta Oncológica | 2020 | 16 |
Improved prognostication of glioblastoma beyond molecular subtyping by transcriptional profiling of the tumor microenvironment | Molecular Oncology | 2020 | 12 |
Sleep quality in hospitalized patients with advanced cancer: an observational study using self-reports of sleep and actigraphy | Supportive Care in Cancer | 2020 | 12 |
High Concordance and Negative Prognostic Impact of RAS/BRAF/PIK3CA Mutations in Multiple Resected Colorectal Liver Metastases | Clinical Colorectal Cancer | 2020 | 11 |
Soluble AXL as a marker of disease progression and survival in melanoma | PLoS ONE | 2020 | 11 |
High symptom burden is associated with impaired quality of life in colorectal cancer patients during chemotherapy:A prospective longitudinal study | European Journal of Oncology Nursing | 2020 | 11 |
Molecular correlates of sensitivity to PARP inhibition beyond homologous recombination deficiency in pre-clinical models of colorectal cancer point to wild-type TP53 activity | EBioMedicine | 2020 | 10 |
Quality indicators in diagnostic upper gastrointestinal endoscopy | Therapeutic Advances in Gastroenterology | 2020 | 9 |
Immune phenotype of tumor microenvironment predicts response to bevacizumab in neoadjuvant treatment of ER-positive breast cancer | International Journal of Cancer | 2020 | 8 |
Targeted alpha therapy for chronic lymphocytic leukaemia and non-Hodgkin's lymphoma with the anti-CD37 radioimmunoconjugate 212Pb-NNV003 | PLoS ONE | 2020 | 8 |
Prediction of survival and progression in glioblastoma patients using temporal perfusion changes during radiochemotherapy | Magnetic Resonance Imaging | 2020 | 8 |
Neoadjuvant chemotherapy is associated with a transient increase of intratumoral T-cell density in microsatellite stable colorectal liver metastases | Cancer Biology and Therapy | 2020 | 8 |
A 10-year prediagnostic follow-up study shows that serum RNA signals are highly dynamic in lung carcinogenesis | Molecular Oncology | 2020 | 8 |
Unmet rehabilitation needs in 86% of Norwegian paediatric embryonal brain tumour survivors | Acta Paediatrica, International Journal of Paediatrics | 2020 | 7 |
Immune stimulatory effect of anti-EpCAM immunotoxin - improved overall survival of metastatic colorectal cancer patients | Acta Oncológica | 2020 | 7 |